MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Accrued expenses
Share-based compensation
Inventory
Others
Negative Cash Flow Breakdown
Accounts receivable
Accounts payable
Income tax payable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-312
-2,230
-1,247
-2,315
Bad debt expense (recovery)
-11
30
-41
76
Amortization of debt discount
99
96
118
123
Amortization of acquired intangible assets
969
1,126
1,065
1,064
Amortization of operating lease right-of-use assets
23
23
23
22
Share-based compensation
1,437
989
1,775
1,854
Accounts receivable
11,243
-4,761
11,759
2,415
Inventory
-1,136
-332
-2,194
-1,034
Prepaid expenses and other current assets
-728
88
1,738
-841
Accounts payable
-153
-649
-2,706
-1,197
Due to related party
-67
17
-300
-85
Accrued expenses
5,729
-1,465
6,374
-1,362
Accrued interest
26
-8
-18
0
Income tax payable
-70
-
-1
0
Lease liabilities
-25
-25
-23
-23
Net cash provided by (used in) operating activities
-1,734
2,909
-6,284
-2,383
Proceeds from the exercise of stock options
158
72
7
103
Proceeds from issuance of common stock, atm offering, net of issuance costs
-
-
5,420
6,891
Proceeds from issuance of common stock under espp
0
148
-1
119
Payment of debt issuance costs
-
-
0
75
Payment of license installment note payable
-
-
0
0
Net cash provided by financing activities
158
220
5,426
7,038
Net change in cash
-1,576
3,129
-858
4,655
Cash at the beginning of the period
27,219
24,090
24,948
20,305
Cash at the end of the period
25,643
27,219
24,090
24,948
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from the
exercise of stock options
$158K
(-34.17%↓ Y/Y)
Net cash provided by
financing activities
$158K
(-95.80%↓ Y/Y)
Net change in cash
-$1,576K
(-13033.33%↓ Y/Y)
Canceled cashflow
$158K
Accrued expenses
$5,729K
(11.52%↑ Y/Y)
Share-based compensation
$1,437K
(-45.96%↓ Y/Y)
Inventory
-$1,136K
(28.06%↑ Y/Y)
Amortization of acquired
intangible assets
$969K
(-54.49%↓ Y/Y)
Prepaid expenses and
other current assets
-$728K
(0.68%↑ Y/Y)
Amortization of debt discount
$99K
(-56.00%↓ Y/Y)
Accrued interest
$26K
(116.67%↑ Y/Y)
Amortization of operating
lease right-of-use...
$23K
(-46.51%↓ Y/Y)
Net cash provided by
(used in) operating...
-$1,734K
(54.05%↑ Y/Y)
Canceled cashflow
$10,147K
Accounts receivable
$11,243K
(117.59%↑ Y/Y)
Net loss
-$312K
(96.04%↑ Y/Y)
Accounts payable
-$153K
(95.36%↑ Y/Y)
Income tax payable
-$70K
(-736.36%↓ Y/Y)
Due to related party
-$67K
(-121.47%↓ Y/Y)
Lease liabilities
-$25K
(30.56%↑ Y/Y)
Bad debt expense
(recovery)
-$11K
(95.53%↑ Y/Y)
Buy us a coffee
Journey Medical Corp (DERM)
Journey Medical Corp (DERM)